{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T11:28:31Z","timestamp":1740137311892,"version":"3.37.3"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,12,14]],"date-time":"2017-12-14T00:00:00Z","timestamp":1513209600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s10238-017-0484-z","type":"journal-article","created":{"date-parts":[[2017,12,14]],"date-time":"2017-12-14T03:18:45Z","timestamp":1513221525000},"page":"245-249","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mediators of angiogenesis and fibrosis in IgG4-related disease"],"prefix":"10.1007","volume":"18","author":[{"given":"Ilaria","family":"Puxeddu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Capecchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Pratesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvana","family":"Cianchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Tavoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6433-4964","authenticated-orcid":false,"given":"Paola","family":"Migliorini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,14]]},"reference":[{"key":"484_CR1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMra1104650","volume":"366","author":"JH Stone","year":"2012","unstructured":"Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366:539\u201351.","journal-title":"N Engl J Med"},{"key":"484_CR2","doi-asserted-by":"crossref","first-page":"e680","DOI":"10.1097\/MD.0000000000000680","volume":"94","author":"D Inoue","year":"2015","unstructured":"Inoue D, Yoshida K, Yoneda N, et al. IgG4-related disease: dataset of 235 consecutive patients. Medicine (Baltimore). 2015;94:e680.","journal-title":"Medicine (Baltimore)"},{"key":"484_CR3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/s10165-011-0571-z","volume":"22","author":"H Umehara","year":"2012","unstructured":"Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol. 2012;22:21\u201330.","journal-title":"Mod Rheumatol"},{"key":"484_CR4","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","volume":"25","author":"V Deshpande","year":"2012","unstructured":"Deshpande V, Zen Y, Chan JK, et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol. 2012;25:1181\u201392.","journal-title":"Mod Pathol"},{"key":"484_CR5","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.jaci.2014.03.034","volume":"134","author":"H Mattoo","year":"2014","unstructured":"Mattoo H, Mahajan VS, Della-Torre E, et al. De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. J Allergy Clin Immunol. 2014;134:679\u201387.","journal-title":"J Allergy Clin Immunol"},{"key":"484_CR6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/hep.28568","volume":"64","author":"ME Doorenspleet","year":"2016","unstructured":"Doorenspleet ME, Hubers LM, Culver EL, et al. Immunoglobulin G4(+) B-cell receptor clones distinguish immunoglobulin G 4-related disease from primary sclerosing cholangitis and biliary\/pancreatic malignancies. Hepatology. 2016;64:501\u20137.","journal-title":"Hepatology"},{"key":"484_CR7","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1136\/annrheumdis-2014-205233","volume":"74","author":"ZS Wallace","year":"2015","unstructured":"Wallace ZS, Mattoo H, Carruthers M, et al. Plasmablasts as a biomarker for IgG4-related disease, independent of serum IgG4 concentrations. Ann Rheum Dis. 2015;74:190\u20135.","journal-title":"Ann Rheum Dis"},{"key":"484_CR8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13075-017-1231-2","volume":"19","author":"W Lin","year":"2017","unstructured":"Lin W, Zhang P, Chen H, et al. Circulating plasmablasts\/plasma cells: a potential biomarker for IgG4-related disease. Arthritis Res Ther. 2017;19:25.","journal-title":"Arthritis Res Ther"},{"key":"484_CR9","doi-asserted-by":"crossref","unstructured":"Grados A, Ebbo M. T cell polarization toward Th2\/TFh2 and Th17\/TFh17 in patients with Igg4-related disease. Front Immunol 2017, in press.","DOI":"10.3389\/fimmu.2017.00235"},{"key":"484_CR10","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.jaci.2015.12.1330","volume":"138","author":"H Mattoo","year":"2016","unstructured":"Mattoo H, Mahajan VS, Maehara T, et al. Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease. J Allergy Clin Immunol. 2016;138:825\u201338.","journal-title":"J Allergy Clin Immunol"},{"key":"484_CR11","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/annrheumdis-2016-209139","volume":"76","author":"T Maehara","year":"2017","unstructured":"Maehara T, Mattoo H, Ohta M, et al. Lesional CD4+ IFN-\u03b3+ cytotoxic T lymphocytes in IgG4-related dacryoadenitis and sialoadenitis. Ann Rheum Dis. 2017;76:377\u201385.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"484_CR12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/cei.12641","volume":"181","author":"E Della-Torre","year":"2015","unstructured":"Della-Torre E, Lanzillotta M, Doglioni C. Immunology of IgG4-related disease. Clin Exp Immunol. 2015;181(2):191\u2013206.","journal-title":"Clin Exp Immunol"},{"key":"484_CR13","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrm809","volume":"3","author":"JJ Tomasek","year":"2002","unstructured":"Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002;3:349\u201363.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"484_CR14","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1136\/annrheumdis-2014-205799","volume":"74","author":"E Della-Torre","year":"2015","unstructured":"Della-Torre E, Feeney E, Deshpande V, et al. B-cell depletion attenuates serological biomarkers of fibrosis and myofibroblast activation in IgG4-related disease. Ann Rheum Dis. 2015;74:2236\u201343.","journal-title":"Ann Rheum Dis"},{"key":"484_CR15","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.3109\/00016489.2013.831187","volume":"133","author":"N Ohta","year":"2013","unstructured":"Ohta N, Kurakami K, Ishida A, et al. Roles of TGF-beta and periostin in fibrosclerosis in patients with IgG4-related diseases. Acta Otolaryngol. 2013;133:1322\u20137.","journal-title":"Acta Otolaryngol"},{"key":"484_CR16","doi-asserted-by":"crossref","first-page":"259408","DOI":"10.1155\/2012\/259408","volume":"2012","author":"MN Carruthers","year":"2012","unstructured":"Carruthers MN, Stone JH, Deshpande V, et al. Development of an IgG4-RD Responder Index. Int J Rheumatol. 2012;2012:259408.","journal-title":"Int J Rheumatol"},{"key":"484_CR17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/MD.0b013e3182433d77","volume":"91","author":"M Ebbo","year":"2012","unstructured":"Ebbo M, Daniel L, Pavic M, et al. IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry. Medicine (Baltimore). 2012;91:49\u201356.","journal-title":"Medicine (Baltimore)"},{"key":"484_CR18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/mi.2016.61","volume":"10","author":"SL Ashley","year":"2017","unstructured":"Ashley SL, Wilke CA, Kim KK, Moore BB. Periostin regulates fibrocyte function to promote myofibroblast differentiation and lung fibrosis. Mucosal Immunol. 2017;10:341\u201351.","journal-title":"Mucosal Immunol"},{"key":"484_CR19","doi-asserted-by":"crossref","first-page":"3201","DOI":"10.1007\/s00018-011-0784-5","volume":"68","author":"A Kudo","year":"2011","unstructured":"Kudo A. Periostin in fibrillogenesis for tissue regeneration: periostin actions inside and outside the cell. Cell Mol Life Sci. 2011;68:3201\u20137.","journal-title":"Cell Mol Life Sci"},{"key":"484_CR20","doi-asserted-by":"crossref","first-page":"e0174547","DOI":"10.1371\/journal.pone.0174547","volume":"12","author":"S Ohta","year":"2017","unstructured":"Ohta S, Okamoto M, Fujimoto K, et al. The usefulness of monomeric periostin as a biomarker for idiopathic pulmonary fibrosis. PLoS ONE. 2017;12:e0174547.","journal-title":"PLoS ONE"},{"key":"484_CR21","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1053\/sonc.2002.37264","volume":"29","author":"N Ferrara","year":"2002","unstructured":"Ferrara N. Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. Semin Oncol. 2002;29:10\u20134.","journal-title":"Semin Oncol"},{"key":"484_CR22","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1517\/13543784.12.6.933","volume":"12","author":"S Tsigkos","year":"2003","unstructured":"Tsigkos S, Koutsilieris M, Papapetropoulos A. Angiopoietins in angiogenesis and beyond. Expert Opin Investig Drugs. 2003;12:933\u201341.","journal-title":"Expert Opin Investig Drugs"},{"key":"484_CR23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jcmgh.2015.06.011","volume":"1","author":"C Bocca","year":"2015","unstructured":"Bocca C, Novo E, Miglietta A, Parola M. Angiogenesis and fibrogenesis in chronic liver diseases. Cell Mol Gastroenterol Hepatol. 2015;1:477\u201388.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"484_CR24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1247\/csf.25.97","volume":"25","author":"UK Zatterstrom","year":"2000","unstructured":"Zatterstrom UK, Felbor U, Fukai N, Olsen BR. Collagen XVIII\/endostatin structure and functional role in angiogenesis. Cell Struct Funct. 2000;25:97\u2013101.","journal-title":"Cell Struct Funct"},{"key":"484_CR25","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/thx.2008.102814","volume":"64","author":"AG Richter","year":"2009","unstructured":"Richter AG, McKeown S, Rathinam S, et al. Soluble endostatin is a novel inhibitor of epithelial repair in idiopathic pulmonary fibrosis. Thorax. 2009;64:156\u201361.","journal-title":"Thorax"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10238-017-0484-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-017-0484-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-017-0484-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,25]],"date-time":"2018-04-25T04:43:09Z","timestamp":1524631389000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10238-017-0484-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,14]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["484"],"URL":"https:\/\/doi.org\/10.1007\/s10238-017-0484-z","relation":{},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"type":"print","value":"1591-8890"},{"type":"electronic","value":"1591-9528"}],"subject":[],"published":{"date-parts":[[2017,12,14]]}}}